Results 281 to 290 of about 3,407,318 (341)
Some of the next articles are maybe not open access.
Pharmacology Mind Maps for Medical Students and Allied Health Professionals, 2019
P. Bhandari
openaire +2 more sources
P. Bhandari
openaire +2 more sources
Pharmacology of Antiplatelet Agents
Current Atherosclerosis Reports, 2013Pharmacotherapies with agents that inhibit platelet function have proven to be effective in the treatment of acute coronary syndromes, and in the prevention of complications during and after percutaneous coronary intervention. Because of multiple synergetic pathways of platelet activation and their close interplay with coagulation, current treatment ...
Kiran, Kalra +7 more
openaire +2 more sources
Antiplatelet Agents for Stroke Prevention
Cerebrovascular Diseases, 2000Antiplatelet agents for stroke ...
Paciaroni M, Gallai V
openaire +3 more sources
Recent Advances in Antiplatelet Agents
Current Medicinal Chemistry, 2002Platelet aggregation plays a key role in the pathogenesis of thromboembolic diseases such as myocardial infarction, stroke, unstable angina and peripheral artery disease. Until recently, aspirin was the only antiplatelet agent available to prevent or treat these events.
Dogné, Jean-Michel +5 more
openaire +3 more sources
High Blood Pressure & Cardiovascular Prevention, 2023
Javad Sharifi‐Rad +14 more
semanticscholar +1 more source
Javad Sharifi‐Rad +14 more
semanticscholar +1 more source
Praxis, 1999
Aspirin has set the gold standard for platelet inhibition in prophylaxis and treatment of cardiovascular diseases. Invasive techniques and novel platelet-inhibitors have fundamentally changed therapeutic approaches to antithrombotic treatment and further diversification is to be expected in the future.
openaire +2 more sources
Aspirin has set the gold standard for platelet inhibition in prophylaxis and treatment of cardiovascular diseases. Invasive techniques and novel platelet-inhibitors have fundamentally changed therapeutic approaches to antithrombotic treatment and further diversification is to be expected in the future.
openaire +2 more sources
Aspirin as an Antiplatelet Agent
Archives of Internal Medicine, 1980To the Editor. —There have been many studies relating the effect of aspirin prophylaxis on thromboembolisms. 1,2 Evaluation of the clinical data presented in them indicates that thromboembolic disease developed more rarely in men than in women under the identical dosage of aspirin given for prophylaxis against thromboembolism after hip surgery and ...
openaire +2 more sources